11 Jan 20245cites
Pro-inflammatory cytokines in spondyloarthritis: a case-control studyPublisher siteExpert Review of Clinical Immunology, Spondyloarthritis Studies and Treatments
Active, last published 2026
In musculoskeletal pain and rehabilitation
Aymen
Tezegdenti
Scholar“Research focused on Musculoskeletal pain and rehabilitation and adjacent fields.”
University of Tunis El Manar
Tunisia
Claim Your ProfileTunisia4
H-index
27
Citations
Aymen has not officially claimed their profile. If you are Aymen, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ymen Tezegdenti is a researcher working on Musculoskeletal pain and rehabilitation. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Aymen's work has been cited 27 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Musculoskeletal pain and rehabilitation×2Psoriasis: Treatment and Pathogenesis×2Spondyloarthritis Studies and Treatments×2
04 · Where I am
Affiliations
Affiliation on published researchMilitary Hospital of Tunis, TunisiaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works1 May 202310cites
Pro-inflammatory cytokines in patients with low back pain: A comparative studyPublisher siteReumatología Clínica (English Edition), Musculoskeletal pain and rehabilitation
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Aymen?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you